Skip to content
TrialScanner

NCT05783622

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Phase 1Active, not recruitingJANXLead

Registry record

Lead sponsor
Janux Therapeutics
Conditions
Non-Small Cell Lung Cancer; Renal Cell Carcinoma; Squamous Cell Carcinoma of the Head and Neck; Colorectal Carcinoma; Small Cell Lung Cancer
Primary completion
Jul 31, 2026Sponsor estimate
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Sponsor estimate: the sponsor registered this date in advance and can move it. A primary completion date is when the last participant is measured, not when results are announced.

Open NCT05783622 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05783622: Study of JANX008 in Subjects... | TrialScanner